Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...

Applied Therapeutics (NASDAQ:APLT – Free Report) had its price objective lowered by Citigroup from $13.00 to $8.00 in a ...

Applied Therapeutics (NASDAQ:APLT – Free Report) had its price objective reduced by Robert W. Baird from $14.00 to $5.00 in a ...

UBS analyst Colin Bristow downgraded Applied Therapeutics (APLT) to Neutral from Buy with a price target of $2, down from $13.Don't Miss our ...

Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

Shares of Applied Therapeutics (APLT) plummeted 76.3% after the FDA rejected approval for its drug intended to treat a rare genetic metabolic disorder. Target Corporation’s (TGT) shares jumped 1.7% on ...

December S&P 500 E-Mini futures (ESZ24) are down -0.12%, andDecember Nasdaq 100 E-Mini futures (NQZ24) are down -0.19% this ...

bunch provides an end-to-end platform for investors to operate, administrate and transact within private markets.

The company said Pat Gelsinger has stepped down, effective yesterday, with Intel naming two interim leaders and starting its ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Russia has fired at least 60 North Korean-supplied ballistic missiles against Ukraine during the war, Radio Free Europe/Radio Liberty reports. Ukrainian military spokesperson Andrii Chernyak told ...

2-Year U.S. Treasury Note Continuous Contract $103.035 0.051 0.05% 5-Year U.S. Treasury Note Continuous Contract $107.594 0.133 0.12% 10-Year U.S. Treasury Note Continuous Contract $111.156 0.250 ...